| 000 | 01338 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250511122246.0 | ||
| 264 | 0 | _c19790221 | |
| 008 | 197902s 0 0 eng d | ||
| 022 | _a0006-2952 | ||
| 024 | 7 |
_a10.1016/0006-2952(78)90325-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCohen, H G | |
| 245 | 0 | 0 |
_aStructural specificity of the NaK-ATPase inhibition by sanguinarine, an isoquinoline benzophenanthridien alkaloid. _h[electronic resource] |
| 260 |
_bBiochemical pharmacology _c1978 |
||
| 300 |
_a2555-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAlkaloids _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBenzophenanthridines |
| 650 | 0 | 4 |
_aBrain _xenzymology |
| 650 | 0 | 4 | _aGuinea Pigs |
| 650 | 0 | 4 | _aIsoquinolines |
| 650 | 0 | 4 |
_aPhenanthridines _xpharmacology |
| 650 | 0 | 4 |
_aSodium-Potassium-Exchanging ATPase _xantagonists & inhibitors |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aSeifen, E E | |
| 700 | 1 | _aStraub, K D | |
| 700 | 1 | _aTiefenback, C | |
| 700 | 1 | _aStermitz, F R | |
| 773 | 0 |
_tBiochemical pharmacology _gvol. 27 _gno. 21 _gp. 2555-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0006-2952(78)90325-8 _zAvailable from publisher's website |
| 999 |
_c240758 _d240758 |
||